Mid-term follow-up of interventional closure of atrial septal defect using Solysafe? Septal Occluder - impact of standardized fluoroscopy for complication detection.
Détails
ID Serval
serval:BIB_7FFD96BF3DBC
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Mid-term follow-up of interventional closure of atrial septal defect using Solysafe? Septal Occluder - impact of standardized fluoroscopy for complication detection.
Périodique
International Journal of Cardiology
ISSN
1874-1754 (Electronic)
ISSN-L
0167-5273
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
152
Numéro
1
Pages
127-128
Langue
anglais
Notes
Publication types: Letter Publication Status: ppublish
Résumé
Interventional closure of secundum type atrial septal defects (ASD II) and patent foramen ovale (PFO) has been developed as standard of care for the majority of pediatric patients, with different types of occlusion devices available [1]. The Solysafe™ Septal Occluder (Swissimplant AG, Solothurn, Switzerland) has been developed for interventional closure of ASD II and PFO and has been evaluated in clinical studies for adult and pediatric patients.
Pubmed
Web of science
Création de la notice
16/12/2014 19:01
Dernière modification de la notice
20/08/2019 15:40
Données d'usage
